F/M Investments’s GoodRx Holdings GDRX Stock Holding History

F/M Investments’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-81,372	Closed	-$3.34M	–	90
2021 Q3	$3.34M	Buy	+81,372	New	+$2.95M	2.39%	8

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

F/M Investments's GDRX Position: Q4 2021 in Review

F/M Investments sold out of GoodRx Holdings (GDRX) in Q4 2021, closing a stake of 81,372 shares — an estimated $3.34M sold.

F/M Investments first reported a position in GDRX in Q3 2021 and held it in 1 quarter. The position peaked at $3.34M in Q3 2021. 216 funds tracked by Wall St. Rank hold GDRX as of Q4 2021.

F/M Investments reported no remaining GoodRx Holdings position as of Q4 2021 after selling out during the quarter.
F/M Investments sold 81,372 GoodRx Holdings shares in Q4 2021, an estimated $3.34M.
F/M Investments first reported a position in GoodRx Holdings in Q3 2021 and held it in 1 quarter.
F/M Investments's GoodRx Holdings position peaked at $3.34M in Q3 2021.
216 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2021.

Based on F/M Investments's 13F filing for Q4 2021, filed 4 Feb 2022.